Go to Top


Gluten Detection

GlutenTox products offer practical tools to detect the most immunogenic fraction of gluten from wheat, rye, barley and some varieties of oat.

Read more

Oleotest is a rapid test to report the quality of used frying oil by estimation of the polar compound Concentration.

Read more

Food analysis service including gluten detection or other food allergens (such as nuts, milk, casein, shell fish. We also offer analysis service including aflatoxins, physicochemical organoleptic, heavy metals, antibiotics, fatty acids, water, nutritional and Microbiological analysis.

Read More

Working on Food Safety

Biomedal Diagnostics is offering various analytical tools to detect harmful agents in food.

Biomedal Diagnostics offers a large variety of products and services related to human health. It already holds a position in the market of products for analysis related to immunological diseases, and rapid tools for food safety analysis. Amongst outstanding products, we offer the latest generation gluten detection tests, GlutenTox, which detects the most immunogenic fraction of gluten. Biomedal Diagnostics also provides Oleotest, a rapid test kit to analyze the quality of used frying oil


Biomedal CB Coria

This season Biomedal appears as the main sponsor of the basketball team known as CB Coria. The team has incorporated in this new campaign the name of the sponsoring company, Biomedal. From now on called Biomedal CB Coria.

The performance of the masculine team, which competes in the 1st National Division in group A, is fulfilling the expectations, taking a balance of 7 wins and 2 defeats, leading their group provisionally. The commitment and work of the players is being irreproachable, and that fact is shown in every match on the court.

New protocol for the early diagnosis of celiac disease

This new protocol was born with the objective of updating the already published in 2008 to promote, homogenize and approximate to the best scientific knowledge the early diagnosis of celiac disease, because it is estimated that despite advances up to 70% of celiac patients remain still without diagnosis.

Gastroenterologist experts in celiac disease (CD) emphasize that it is a difficult disease to diagnose due to the systemic nature of the disease, with involvement of multiple organs and systems, and also the lack of specificity of its clinical manifestations. In addition, the clinical characteristics of the disease differ considerably depending on the age of presentation.

It is necessary to carry out a clinical follow-up of the patients, with the objective of monitoring and evaluating their evolution, as well as compliance with the gluten-free diet and controlling growth in children. In those patients who continue with symptoms despite being on a gluten-free diet, it is mandatory to carry out an intentional search for hidden sources of gluten in the diet or minimal transgressions.

The information has been extracted from the official document drafted by the Ministry of Health.


The most important points of the new protocol are:

  •  Its emphasis is placed on the importance of ensuring that the patient continues consuming gluten before the beginning of the celiac disease diagnosis, because this will cause the fall in antibodies levels and give false negatives that will difficult the disease diagnose.
  • Clinical monitoring of celiac patients is necessary, in order to monitor and assess the evolution of their symptoms and the degree of compliance with the gluten-free diet, in addition to controlling the correct growth in the case of pediatric patients.
  • This document catalogue gluten immunogenic peptides (GIP) as the most effective method for the monitoring of the gluten-free diet, assess transgressions in the diet and dismiss the involuntary intake of gluten during the diagnosis of refractory CD.
  • It is possible that celiac patients have negative levels of antibodies. In these cases, genetic tests can help to diagnose the disease. In addition, this test is useful to identify individuals with a high risk of developing CD between first-degree relatives and patients with associated diseases who have positive serology and normal biopsy.
  • Except in pediatric patients and in very specific cases, the CD diagnosis requires a duodenal biopsy showing the atrophy of the intestinal villi characteristic of this disease.


To read the complete protocol, please click on the following link: